PANEL DISCUSSION: Where are the Biggest Bottlenecks for Gene Therapy Immunogenicity & Which Approaches are Showing Most Promise (and Feasibility)?
Time: 2:30 pm
day: Post-Conference Discussion Day - Track A
- Actively minimizing immunogenic responses
- How close are we to redosing?
- Widening patient eligibility in relation to antibody positivity
- Exploring innovative vector modifications